Zuberitamab

Indication: 用于CD20阳性弥漫大B细胞淋巴瘤，非特指性（DLBCL，NOS）成人患者，应与标准CHOP化疗（环磷酰胺、阿霉素、长春新碱、泼尼松）联合治疗。

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.